BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

674 related articles for article (PubMed ID: 16414153)

  • 1. [Venous thromboembolism and cancer].
    Pavic M; Debourdeau P; Aletti M; Farge-Bancel D; Rousset H
    Rev Med Interne; 2006 Apr; 27(4):313-22. PubMed ID: 16414153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Venous thromboembolism associated with long-term use of central venous catheters in cancer patients.
    Verso M; Agnelli G
    J Clin Oncol; 2003 Oct; 21(19):3665-75. PubMed ID: 14512399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Venous thromboembolism and cancer: prevention and therapy.
    Lee AY
    Vnitr Lek; 2006 Mar; 52 Suppl 1():127-8, 130-1. PubMed ID: 16637461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombosis and cancer.
    Kakkar AK
    Hematol J; 2004; 5 Suppl 3():S20-3. PubMed ID: 15190272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evidence-based guidelines for prevention and therapy of venous thromboembolism].
    Falciani M; Dilaghi B; Conti AA; Caciolli S; Gensini GF
    Minerva Cardioangiol; 2000 Dec; 48(12 Suppl 1):27-35. PubMed ID: 11253337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of venous thrombosis in cancer patients: practical aspects].
    Laza-Achille M; Desruennes E; Di Palma M
    Bull Cancer; 2006 Mar; 93(3):271-81. PubMed ID: 16567314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of low-molecular-weight heparins as supportive care therapy in cancer-associated thrombosis.
    Cunningham RS
    Semin Oncol; 2006 Apr; 33(2 Suppl 4):S17-25; quiz S41-2. PubMed ID: 16638457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Venous thromboembolism in oncologic patients: guidelines for prevention and therapy and areas of uncertainty].
    Di Minno G; Tufano A
    Tumori; 2006; 92(6):suppl 1-15. PubMed ID: 17260505
    [No Abstract]   [Full Text] [Related]  

  • 9. Low-molecular-weight heparin or oral anticoagulation for secondary prevention of deep vein thrombosis in cancer patients.
    Levine M
    Semin Thromb Hemost; 2003 Dec; 29 Suppl 1():9-11. PubMed ID: 14730472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venous thromboembolism in patients with active cancer.
    Seddighzadeh A; Shetty R; Goldhaber SZ
    Thromb Haemost; 2007 Sep; 98(3):656-61. PubMed ID: 17849056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer and venous thromboembolism.
    Prandoni P; Falanga A; Piccioli A
    Lancet Oncol; 2005 Jun; 6(6):401-10. PubMed ID: 15925818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thromboembolic complications of cancer: epidemiology, pathogenesis, diagnosis, and treatment.
    Sutherland DE; Weitz IC; Liebman HA
    Am J Hematol; 2003 Jan; 72(1):43-52. PubMed ID: 12508268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of venous thromboembolism in the geriatric patient.
    Jaffer AK; Brotman DJ
    Clin Geriatr Med; 2006 Feb; 22(1):93-111, ix. PubMed ID: 16377469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylaxis and treatment of venous thromboembolism in patients with cancer: an update.
    Falciani M; Imberti D; Prisco D
    Intern Emerg Med; 2006; 1(4):273-8. PubMed ID: 17217148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-molecular-weight heparin versus oral anticoagulant therapy for the long-term treatment of symptomatic venous thromboembolism: Is there any difference in cancer-related mortality?
    Ferretti G; Bria E; Giannarelli D; Carlini P; Felici A; Mandala M; Papaldo P; Nistico C; Fabi A; Cuppone F; Gelibter A; Terzoli E; Cognetti F
    J Clin Oncol; 2005 Oct; 23(28):7248-50; author reply 7250. PubMed ID: 16192623
    [No Abstract]   [Full Text] [Related]  

  • 16. [Occult cancer and venous thromboembolism].
    Lévesque H
    Rev Med Interne; 2006 Apr; 27(4):273-5. PubMed ID: 16516354
    [No Abstract]   [Full Text] [Related]  

  • 17. Cancer and venous thromboembolism. Clinical implications of strong association.
    Prandoni P
    Pathophysiol Haemost Thromb; 2006; 35(1-2):111-5. PubMed ID: 16855355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of low molecular weight heparins in prophylaxis of thromboembolic events on oncological patients with indwelling central venous catheter].
    Calderero Aragón V; de Gregorio Ariza MA; Pazo Cid R; Puértolas Hernández T; Lostalé Latorre F; Artal Cortés A; Antón Torres A
    Med Clin (Barc); 2009 Sep; 133(10):365-70. PubMed ID: 19646715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic indications for acute venous thromboembolism. Current status and future perspectives].
    Prandoni P; Simioni P; Pagnan A
    Minerva Cardioangiol; 2003 Aug; 51(4):361-71. PubMed ID: 12900718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylaxis of catheter-related deep vein thrombosis in cancer patients with low-dose warfarin, low molecular weight heparin, or control: a randomized, controlled, phase III study.
    Lavau-Denes S; Lacroix P; Maubon A; Preux PM; Genet D; Vénat-Bouvet L; Labourey JL; Martin J; Slaouti P; Tubiana-Mathieu N
    Cancer Chemother Pharmacol; 2013 Jul; 72(1):65-73. PubMed ID: 23636449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.